Article Text

Download PDFPDF
▼Linezolid for Gram-positive infections
  • Relevant BNF section: 5.1.7


&#9660Linezolid* (Zyvox - Pharmacia) - the first oxazolidinone antibacterial - is marketed in the UK for treating hospital- and community-acquired pneumonia, skin and soft tissue infections. The manufacturer claims that switching from i.v. to oral administration of linezolid needs no dose adjustment and "will lead to early patient discharge and reduced hospital length of stay" for patients needing treatment for infections caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA).1 Here, we assess the place of linezolid.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

  • Relevant BNF section: 5.1.7

View Full Text